3D bioprinting is an innovative technology that promises to revolutionize cancer research and treatment by providing more accurate and complex models of tumor tissue. This advancement is particularly significant in the study of cancers involving the BRCA1 gene. Tumor modeling with 3D bioprinting
The transformative impact of a historic AI infrastructure investment on the drug discovery and healthcare sectors is becoming increasingly evident. This $500 billion investment, spearheaded by Stargate—a collaborative venture between OpenAI, SoftBank, and Oracle—aims to fast-track breakthroughs in
BeiGene Ltd., one of China's foremost developers of next-generation cancer drugs, is on the cusp of turning a profit after years of significant investments in research and development. The company has made remarkable strides towards achieving an annual operating profit, bolstered by the successful
A groundbreaking study conducted by Zeynep Ilgin Kolabas and her colleagues at Ludwig Maximilian University of Munich unveils the existence and function of channels between the skull and brain. This research reveals their role in trafficking immune cells and facilitating skull-specific immune
The field of cell therapy is currently witnessing groundbreaking advancements, particularly in the methods of stem cell collection and the automation of manufacturing processes. These innovations hold the potential to revolutionize the sector by significantly enhancing the efficiency, reliability,
In today's rapidly evolving scientific landscape, groundbreaking innovations are consistently transforming our understanding of the world and pushing the boundaries of what is possible. From space exploration to bioengineering, researchers are uncovering new knowledge and developing technologies
